Zoetis Inc (ZTS)
175.14
+0.51
(+0.29%)
USD |
NYSE |
Nov 15, 16:00
175.00
-0.14
(-0.08%)
Pre-Market: 07:17
Zoetis Price: 175.14 for Nov. 15, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 15, 2024 | 172.91 | 177.06 | 170.75 | 175.14 | 3.423M |
Nov 14, 2024 | 177.48 | 178.97 | 173.81 | 174.63 | 3.010M |
Nov 13, 2024 | 175.32 | 177.50 | 174.91 | 177.04 | 2.375M |
Nov 12, 2024 | 175.39 | 176.51 | 173.75 | 173.96 | 2.704M |
Nov 11, 2024 | 176.98 | 178.38 | 175.00 | 176.15 | 3.400M |
Nov 08, 2024 | 174.25 | 177.10 | 173.22 | 176.82 | 3.243M |
Nov 07, 2024 | 172.59 | 174.78 | 169.64 | 174.25 | 3.781M |
Nov 06, 2024 | 178.52 | 178.92 | 169.31 | 170.37 | 5.362M |
Nov 05, 2024 | 174.56 | 176.80 | 172.25 | 175.27 | 2.454M |
Nov 04, 2024 | 176.64 | 179.17 | 173.59 | 175.18 | 4.164M |
Nov 01, 2024 | 179.98 | 183.11 | 179.20 | 181.95 | 2.839M |
Oct 31, 2024 | 180.22 | 181.58 | 178.74 | 178.78 | 2.120M |
Oct 30, 2024 | 179.92 | 183.81 | 179.80 | 182.74 | 1.958M |
Oct 29, 2024 | 182.01 | 184.40 | 181.04 | 181.27 | 1.696M |
Oct 28, 2024 | 181.53 | 183.10 | 180.70 | 182.76 | 1.910M |
Oct 25, 2024 | 181.49 | 182.03 | 179.67 | 180.01 | 2.623M |
Oct 24, 2024 | 187.56 | 188.25 | 180.06 | 181.50 | 4.486M |
Oct 23, 2024 | 189.40 | 189.98 | 187.56 | 188.99 | 1.339M |
Oct 22, 2024 | 188.41 | 189.82 | 187.22 | 189.51 | 1.442M |
Oct 21, 2024 | 192.48 | 193.00 | 189.18 | 189.45 | 959465.0 |
Oct 18, 2024 | 191.16 | 193.49 | 190.50 | 193.28 | 1.576M |
Oct 17, 2024 | 195.71 | 196.55 | 190.89 | 191.00 | 1.701M |
Oct 16, 2024 | 192.00 | 195.88 | 191.76 | 194.44 | 1.592M |
Oct 15, 2024 | 192.28 | 195.82 | 191.94 | 192.39 | 1.415M |
Oct 14, 2024 | 190.16 | 193.04 | 189.79 | 192.65 | 1.616M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
92.66
Minimum
Mar 23 2020
247.03
Maximum
Dec 29 2021
170.39
Average
170.16
Median
Price Benchmarks
Pfizer Inc | 24.80 |
Regeneron Pharmaceuticals Inc | 756.81 |
Vertex Pharmaceuticals Inc | 465.70 |
Alnylam Pharmaceuticals Inc | 235.56 |
Biomarin Pharmaceutical Inc | 63.42 |
Price Related Metrics
PE Ratio | 32.92 |
PS Ratio | 8.747 |
PEG Ratio | 4.049 |
Price to Book Value | 15.10 |
Price to Free Cash Flow | 34.69 |
Earnings Yield | 3.04% |
Market Cap | 79.02B |
PEGY Ratio | 3.611 |
Operating PE Ratio | 24.00 |
Normalized PE Ratio | 31.29 |